About Cornileus Pharmaceuticals
Cornileus Pharmaceuticals is a company. The company has 124 employees as of March 29, 2024. Cornileus Pharmaceuticals offers products and services including Pellets and Sugar or MCC Spheres.
- Employees 124 as on 29 Mar, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
- Legal Name Cornileus Pharmaceuticals Pvt Ltd
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$4.85 M (USD)14.7as on Mar 31, 2023
-
Net Profit
$650.26 K (USD)-11.13as on Mar 31, 2023
-
EBITDA
$1.08 M (USD)-20.89as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
124
as on Mar 29, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cornileus Pharmaceuticals
Cornileus Pharmaceuticals offers a comprehensive portfolio of products and services, including Pellets and Sugar or MCC Spheres.
Research, manufacturing, and marketing of pharmaceutical pellets are carried out by the company for healthcare solutions.
Production and distribution of sugar or MCC spheres are managed by the company as part of its formulation offerings.
Funding Insights of Cornileus Pharmaceuticals
Detailed funding history for Cornileus Pharmaceuticals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cornileus Pharmaceuticals
Investment portfolio details for Cornileus Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cornileus Pharmaceuticals
Detailed financials for Cornileus Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cornileus Pharmaceuticals Comparisons
Peer comparison for Cornileus Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cornileus Pharmaceuticals
Detailed competitors of Cornileus Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cornileus Pharmaceuticals
Complete news archive for Cornileus Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cornileus Pharmaceuticals
As of Mar 29, 2024, the latest employee count at Cornileus Pharmaceuticals is 124.
Annual revenue of Cornileus Pharmaceuticals is $4.85M as on Mar 31, 2023.
Cornileus Pharmaceuticals is engaged in research and development, manufacturing, and marketing of pharmaceutical pellets and related formulations, with facilities located in Visakhapatnam that adhere to cGMP guidelines. Global operations are extended across countries like Mexico, Brazil, and China to deliver healthcare solutions. Quality control measures are implemented to ensure compliance, while continuous product development is pursued to meet market demands. The companys efforts are focused on serving clients through professional approaches in the pharmaceutical sector.
Cornileus Pharmaceuticals offers Pellets and Sugar or MCC Spheres.